Images Powered by Shutterstock
No Luck for Chemo-Free Tx in First-Line Bladder Cancer

No Luck for Chemo-Free Tx in First-Line Bladder Cancer

PD-L1 checkpoint blockade with or without anti-CTLA-4 failed to improve overall survival (OS) compared to standard chemotherapy in previously untreated metastatic bladder...

Immunotherapy improves survival in patients with advanced bladder cancer

Immunotherapy improves survival in patients with advanced bladder cancer

An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a...

Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies.

Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies.

There is an urgent need to provide a risk-stratification tool for intermediate-risk non-muscle-invasive bladder cancer (NMIBC), especially at the time of bacillus...

Chemo Plus Immunotherapy Shows Promise for Advanced Bladder Cancer

Chemo Plus Immunotherapy Shows Promise for Advanced Bladder Cancer

The combination of nivolumab, gemcitabine and cisplatin produces significant pathologic response rates in patients with muscle-invasive bladder cancer (MIBC) in the neoadjuvant...

Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review

Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review

Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a... Comparison of cross-sectional imaging techniques for the...

Why aren’t advanced bladder cancers being treated?

Why aren’t advanced bladder cancers being treated?

Newswise — Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder...

Bavencio Shows Benefit as 1st-line Maintenance Therapy for Bladder...

Bavencio Shows Benefit as 1st-line Maintenance Therapy for Bladder...

First-line maintenance therapy with Bavencio (avelumab) significantly delays disease progression or death in people with inoperable, locally advanced or metastatic urothelial...

Infigratinib Appears Active Across All Lines of Treatment in Patients With Advanced Bladder Cancer

Infigratinib Appears Active Across All Lines of Treatment in Patients With Advanced Bladder Cancer

Results of a retrospective analysis presented at the 2020 ASCO Virtual Scientific Program show that infigratinib demonstrates clinical activity in patients with metastatic...

Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence

Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence

Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence BMC Urology volume 20, Article number: 64 (2020) Cite this article 91...

No Higher Death Risk with Fewer Cystoscopies for NIMBC

No Higher Death Risk with Fewer Cystoscopies for NIMBC

Low-intensity cystoscopic surveillance of high-risk non-muscle-invasive bladder cancer (NMIBC) led to fewer transurethral resections without increasing the risk of fatal bladder...

Can Mitomycin Gel Defer Surgery for Low-Grade Early Bladder Cancer?

Can Mitomycin Gel Defer Surgery for Low-Grade Early Bladder Cancer?

Two thirds of patients with low-grade intermediate-risk non-muscle-invasive bladder cancer (NMIBC) achieved complete responses (CRs) and deferred surgery after primary...

Growth Factors Play Emerging Role in Bladder Cancer

Growth Factors Play Emerging Role in Bladder Cancer

When checkpoint inhibitorswere introduced, it had been more than 30 years since any new drugs had been approved for the treatment of urothelial cancer. Recently, 2 new...